Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
{{id}} {{{paragraph}}}
Example: bankruptcy
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - …
HIGHLIGHTS OF PRESCRIBING INFORMATION These HIGHLIGHTS do not include all the INFORMATION needed to use VESI care safely and effectively. See full PRESCRIBING INFORMATION for VESI care. VESI care (solifenacin succinate) tablets Initial Approval: 2004 ----------------------------INDICATIONS AND USAGE--------------------------- VESI care is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency (1). ----------------------DOSAGE AND ADMINISTRATION----------------------- 5 mg tablet taken once daily, and if well tolerated may be increased to 10 mg once daily ( ). Do not exceed 5 mg tablet once daily in patients with: o severe renal impairment [Creatinine Clearance] (CLcr < 30 mL/min) ( ). o moderate hepatic impairment (Child-Pugh B) ( ).
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VESIcare® safely and effectively. See full prescribing information …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: